Antimicrobial Activity of Doripenem and Other Carbapenems Against Gram-Negative Pathogens from Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antimicrobial Activity of Doripenem and Other Carbapenems Against Gram-Negative Pathogens from Korea

Published:2011-03 Issue:1 Volume:17 Page:37-45
ISSN:1076-6294
Container-title:Microbial Drug Resistance
language:en
Short-container-title:Microbial Drug Resistance

Author:

Lee Harim¹,Ko Kwan Soo¹²,Song Jae-Hoon¹³,Peck Kyong Ran³

Affiliation:

1. Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Korea.

2. Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea.

3. Division of Infection Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

Mary Ann Liebert Inc

Subject

Microbiology (medical),Pharmacology,Immunology,Microbiology

Link

http://www.liebertpub.com/doi/pdf/10.1089/mdr.2010.0034

Reference20 articles.

1. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

2. Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control

3. Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and Pseudomonas aeruginosa

4. 5.DoribaxTM (doripenem for injection) [package insert].2009. Ortho-McNeil Pharmaceuticals, Raritan, NJ.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations;Antibiotics;2022-07-16

2. Biotyping, virulotyping and biofilm formation ability of ESBL-Klebsiella pneumoniae isolates from nosocomial infections;Journal of Applied Microbiology;2022-06-01

3. Population Pharmacokinetic Analysis of Meropenem After Intravenous Infusion in Korean Patients With Acute Infections;Clinical Therapeutics;2018-08

4. Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections;PLOS ONE;2016-12-01

5. Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii;Journal of Applied Microbiology;2016-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3